• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米托卡尼二萜和三萜类罗丹明 B 缀合物。

Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.

机构信息

Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Street 2, D-06120 Halle, Germany.

Medical and Life Science Faculty, Institute of Precision Medicine, Furtwangen University, Jakob-Kienzle-Street 17, D-78054 Villigen-Schwenningen, Germany.

出版信息

Molecules. 2020 Nov 20;25(22):5443. doi: 10.3390/molecules25225443.

DOI:10.3390/molecules25225443
PMID:33233650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7699795/
Abstract

The combination of the "correct" triterpenoid, the "correct" spacer and rhodamine B () seems to be decisive for the ability of the conjugate to accumulate in mitochondria. So far, several triterpenoid rhodamine B conjugates have been prepared and screened for their cytotoxic activity. To obtain cytotoxic compounds with EC values in a low nano-molar range combined with good tumor/non-tumor selectivity, the Rho B unit has to be attached via an amine spacer to the terpenoid skeleton. To avoid spirolactamization, secondary amines have to be used. First results indicate that a homopiperazinyl spacer is superior to a piperazinyl spacer. Hybrids derived from maslinic acid or tormentic acid are superior to those from oleanolic, ursolic, glycyrrhetinic or euscaphic acid. Thus, a tormentic acid-derived conjugate , holding a homopiperazinyl spacer can be regarded, at present, as the most promising candidate for further biological studies.

摘要

“正确”的三萜、“正确”的间隔基与若丹明 B(rhodamine B)的结合似乎对缀合物在线粒体中积累的能力起着决定性作用。迄今为止,已经制备并筛选了几种三萜若丹明 B 缀合物以研究其细胞毒性。为了获得 EC 值在低纳摩尔范围内的具有细胞毒性的化合物,同时保持良好的肿瘤/非肿瘤选择性,Rho B 单元必须通过胺间隔基连接到萜烯骨架上。为了避免螺内酰胺化,必须使用仲胺。初步结果表明,同哌嗪基间隔基优于哌嗪基间隔基。来源于齐墩果酸或熊果酸的杂种优于来源于乌苏酸、熊果酸、甘草次酸或羽扇豆酸的杂种。因此,目前认为来源于熊果酸的具有同哌嗪基间隔基的缀合物是进一步进行生物学研究的最有前途的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/fe69c1142ed2/molecules-25-05443-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/e27a01d08ec2/molecules-25-05443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/2052be494529/molecules-25-05443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/a3fdd3296410/molecules-25-05443-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/e5192d5a2904/molecules-25-05443-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/1058e174232a/molecules-25-05443-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/1d5ac8c44960/molecules-25-05443-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/16577805987d/molecules-25-05443-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/0fcfa6dc2f15/molecules-25-05443-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/adeafa1113cc/molecules-25-05443-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/fe69c1142ed2/molecules-25-05443-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/e27a01d08ec2/molecules-25-05443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/2052be494529/molecules-25-05443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/a3fdd3296410/molecules-25-05443-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/e5192d5a2904/molecules-25-05443-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/1058e174232a/molecules-25-05443-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/1d5ac8c44960/molecules-25-05443-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/16577805987d/molecules-25-05443-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/0fcfa6dc2f15/molecules-25-05443-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/adeafa1113cc/molecules-25-05443-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc18/7699795/fe69c1142ed2/molecules-25-05443-g010.jpg

相似文献

1
Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.米托卡尼二萜和三萜类罗丹明 B 缀合物。
Molecules. 2020 Nov 20;25(22):5443. doi: 10.3390/molecules25225443.
2
Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.三萜酸的罗丹明B共轭物即使在纳摩尔浓度下也是具有细胞毒性的线粒体靶向剂。
Eur J Med Chem. 2017 Feb 15;127:1-9. doi: 10.1016/j.ejmech.2016.12.040. Epub 2016 Dec 23.
3
Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.三萜酰胺类化合物的若丹明 101 缀合物与它们的若丹明 B 类似物具有相当的细胞毒性。
Molecules. 2022 Mar 29;27(7):2220. doi: 10.3390/molecules27072220.
4
Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.三萜酸同哌嗪罗丹明 B 的加合物是强的线粒体靶向药物。
Eur J Med Chem. 2018 Jul 15;155:869-879. doi: 10.1016/j.ejmech.2018.06.051. Epub 2018 Jun 27.
5
Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.靶向线粒体:具有三萜的罗丹明 B 酯类是细胞凋亡的Mitocanic 触发剂。
Eur J Med Chem. 2018 May 25;152:21-30. doi: 10.1016/j.ejmech.2018.04.031. Epub 2018 Apr 17.
6
Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids.键合类型和位置决定了齐墩果酸罗丹明 B 杂化物的细胞毒性。
Steroids. 2021 Aug;172:108876. doi: 10.1016/j.steroids.2021.108876. Epub 2021 Jun 12.
7
Developing an Amide-Spacered Triterpenoid Rhodamine Hybrid of Nano-Molar Cytotoxicity Combined with Excellent Tumor Cell/Non-Tumor Cell Selectivity.开发出一种具有纳摩尔细胞毒性的酰胺间隔三萜类罗丹明杂合体,具有优异的肿瘤细胞/非肿瘤细胞选择性。
Molecules. 2023 Sep 1;28(17):6404. doi: 10.3390/molecules28176404.
8
Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.合成具有增强细胞毒性的洛拉明偶联的羽扇豆烷型三萜。
Molecules. 2024 May 16;29(10):2346. doi: 10.3390/molecules29102346.
9
Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.BODIPY FL 标记三萜类化合物的设计、合成与细胞毒性。
Eur J Med Chem. 2020 Jan 1;185:111858. doi: 10.1016/j.ejmech.2019.111858. Epub 2019 Nov 6.
10
The Finally Rewarding Search for A Cytotoxic Isosteviol Derivative.最终找到了具有细胞毒性的异甜菊醇衍生物。
Molecules. 2023 Jun 23;28(13):4951. doi: 10.3390/molecules28134951.

引用本文的文献

1
Fluorescence Labeling of Peptides: Finding the Optimal Protocol for Coupling Various Dyes to ATCUN-like Structures.肽的荧光标记:寻找将各种染料偶联至类ATCUN结构的最佳方案
ACS Org Inorg Au. 2024 Jun 4;4(5):517-525. doi: 10.1021/acsorginorgau.4c00030. eCollection 2024 Oct 2.
2
Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.合成具有增强细胞毒性的洛拉明偶联的羽扇豆烷型三萜。
Molecules. 2024 May 16;29(10):2346. doi: 10.3390/molecules29102346.
3
Terpenes and Terpenoids Conjugated with BODIPYs: An Overview of Biological and Chemical Properties.

本文引用的文献

1
Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.细胞毒性三萜类化合物-鲨烯离子轭合物靶向内质网。
Eur J Med Chem. 2021 Jan 1;209:112920. doi: 10.1016/j.ejmech.2020.112920. Epub 2020 Oct 8.
2
The presence of a cationic center is not alone decisive for the cytotoxicity of triterpene carboxylic acid amides.三萜羧酸酰胺的细胞毒性不仅仅取决于阳离子中心的存在。
Steroids. 2020 Nov;163:108713. doi: 10.1016/j.steroids.2020.108713. Epub 2020 Aug 12.
3
Treatment compliance in early-stage anal cancer.早期肛门癌的治疗依从性
萜类和类萜与 BODIPY 共轭:生物和化学性质概述。
J Nat Prod. 2024 Apr 26;87(4):1306-1319. doi: 10.1021/acs.jnatprod.3c00961. Epub 2024 Mar 14.
4
F16 Hybrids Derived from Steviol or Isosteviol Are Accumulated in the Mitochondria of Tumor Cells and Overcome Drug Resistance.甜菊醇或异甜菊醇衍生的 F16 杂种在肿瘤细胞的线粒体中积累,并克服耐药性。
Molecules. 2024 Jan 12;29(2):381. doi: 10.3390/molecules29020381.
5
Developing an Amide-Spacered Triterpenoid Rhodamine Hybrid of Nano-Molar Cytotoxicity Combined with Excellent Tumor Cell/Non-Tumor Cell Selectivity.开发出一种具有纳摩尔细胞毒性的酰胺间隔三萜类罗丹明杂合体,具有优异的肿瘤细胞/非肿瘤细胞选择性。
Molecules. 2023 Sep 1;28(17):6404. doi: 10.3390/molecules28176404.
6
The Finally Rewarding Search for A Cytotoxic Isosteviol Derivative.最终找到了具有细胞毒性的异甜菊醇衍生物。
Molecules. 2023 Jun 23;28(13):4951. doi: 10.3390/molecules28134951.
7
Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration against Breast Cancer Cells.线粒体靶向 1,5-二氮杂环辛烷间隔三萜类罗丹明缀合物以亚纳摩尔浓度对乳腺癌细胞表现出细胞毒性。
Int J Mol Sci. 2023 Jun 27;24(13):10695. doi: 10.3390/ijms241310695.
8
Conjugation of Triterpenic Acids of Ursane and Oleanane Types with Mitochondria-Targeting Cation F16 Synergistically Enhanced Their Cytotoxicity against Tumor Cells.乌苏烷型和齐墩果烷型三萜酸与线粒体靶向阳离子F16的缀合协同增强了它们对肿瘤细胞的细胞毒性。
Membranes (Basel). 2023 May 30;13(6):563. doi: 10.3390/membranes13060563.
9
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.线粒体遗传和表观遗传调控在癌症中的作用:治疗潜力。
Int J Mol Sci. 2022 Jul 18;23(14):7897. doi: 10.3390/ijms23147897.
10
Targeting Energy Metabolism in Cancer Treatment.靶向癌症治疗中的能量代谢。
Int J Mol Sci. 2022 May 16;23(10):5572. doi: 10.3390/ijms23105572.
Ann Oncol. 2020 Oct;31(10):1282-1284. doi: 10.1016/j.annonc.2020.07.006. Epub 2020 Jul 22.
4
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity.一种用于准确测定米托坎细胞毒性的自动核差异染色分析方法。
J Vis Exp. 2020 May 12(159). doi: 10.3791/61295.
5
Synthesis of some steroidal mitocans of nanomolar cytotoxicity acting by apoptosis.一些具有纳米级细胞毒性的甾体米托坎的合成,这些化合物通过细胞凋亡发挥作用。
Eur J Med Chem. 2020 Aug 1;199:112425. doi: 10.1016/j.ejmech.2020.112425. Epub 2020 May 11.
6
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy.利用线粒体靶向药物的协同潜力治疗白血病
Front Oncol. 2020 Apr 3;10:435. doi: 10.3389/fonc.2020.00435. eCollection 2020.
7
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
8
Mitochondria-targeted compounds in the treatment of cancer.线粒体靶向化合物在癌症治疗中的应用。
Neoplasma. 2020 May;67(3):450-460. doi: 10.4149/neo_2020_190725N671. Epub 2020 Feb 28.
9
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.临床肿瘤学进展 2020:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2020 Apr 1;38(10):1081. doi: 10.1200/JCO.19.03141. Epub 2020 Feb 4.
10
Precision Medicine in Lymphoma by Innovative Instrumental Platforms.创新仪器平台助力淋巴瘤的精准医学
Front Oncol. 2019 Dec 17;9:1417. doi: 10.3389/fonc.2019.01417. eCollection 2019.